Evidence-based pain pharmacology for pigs enables welfare-positive management of surgical procedures and chronic conditions. Understanding species-specific pharmacokinetics guides appropriate treatment.
Pig pain pharmacology has advanced significantly in recent years with validated assessment tools and evidence-based treatment protocols that reduce the welfare gap between recognized pain and appropriate treatment. The barrier to pain management in commercial pig production is primarily economic and cultural rather than pharmacological: appropriate drugs exist, their welfare benefit is documented, and their cost is modest relative to production value. The welfare standard requires that painful procedures are accompanied by appropriate multimodal analgesia combining local anesthesia for procedural pain, NSAIDs for inflammatory pain, and opioids for severe acute pain where regulatory frameworks permit.